{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:09:14Z","timestamp":1787501354201,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.neulet.2016.09.020","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T18:34:01Z","timestamp":1473964441000},"page":"87-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia"],"prefix":"10.1016","volume":"633","author":[{"given":"Edina","family":"Sz\u0171cs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szabolcs","family":"Dvor\u00e1csk\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"T\u00f6mb\u00f6ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"B\u00fcki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"K\u00e9kesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6ngyi","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e1ndor","family":"Benyhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.neulet.2016.09.020_bib0005","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1007\/BF00442554","article-title":"Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia","volume":"99","author":"Meltzer","year":"1989","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neulet.2016.09.020_bib0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/schbul\/16.3.425","article-title":"Schizophrenia: a subcortical neurotransmitter imbalance syndrome?","volume":"16","author":"Carlsson","year":"1990","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neulet.2016.09.020_bib0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2016.09.020_bib0020","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III\u2014the final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neulet.2016.09.020_bib0025","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0304-3940(80)90178-0","article-title":"Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia","volume":"20","author":"Kim","year":"1980","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2016.09.020_bib0030","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10673229609017192","article-title":"The glutamatergic dysfunction hypothesis for schizophrenia","volume":"3","author":"Coyle","year":"1996","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.neulet.2016.09.020_bib0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment","volume":"37","author":"Moghaddam","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2016.09.020_bib0040","first-page":"295","article-title":"The 5-HT hypothesis of schizophrenia","volume":"4","author":"Akhondzadeh","year":"2001","journal-title":"IDrugs"},{"key":"10.1016\/j.neulet.2016.09.020_bib0045","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.mehy.2013.03.013","article-title":"A serotonin hypothesis of schizophrenia","volume":"80","author":"Eggers","year":"2013","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.neulet.2016.09.020_bib0050","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.pneurobio.2010.06.010","article-title":"Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia","volume":"92","author":"Bossong","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neulet.2016.09.020_bib0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/00048670801961156","article-title":"Cannabis, cannabinoids and schizophrenia: integration of the evidence","volume":"42","author":"Cohen","year":"2008","journal-title":"Aust. N.Z. J. Psychiatry"},{"key":"10.1016\/j.neulet.2016.09.020_bib0060","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1097\/00001756-199906030-00008","article-title":"Elevated endogenous cannabinoids in schizophrenia","volume":"10","author":"Leweke","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.neulet.2016.09.020_bib0065","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/archpsyc.65.7.772","article-title":"Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia","volume":"65","author":"Eggan","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neulet.2016.09.020_bib0070","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.biopsych.2015.08.021","article-title":"Reduced brain cannabinoid receptor availability in schizophrenia","volume":"79","author":"Ranganathan","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.neulet.2016.09.020_bib0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1590\/S1807-59322011001300009","article-title":"The role of the cerebellum in schizophrenia: from cognition to molecular pathways","volume":"66","author":"Yeganeh-Doost","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.neulet.2016.09.020_bib0080","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fnsys.2014.00163","article-title":"The therapeutic potential of the cerebellum in schizophrenia","volume":"8","author":"Parker","year":"2014","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.neulet.2016.09.020_bib0085","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/nn.2647","article-title":"Animal models of neuropsychiatric disorders","volume":"13","author":"Nestler","year":"2010","journal-title":"Nature Neurosci."},{"key":"10.1016\/j.neulet.2016.09.020_bib0090","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1476-5381.2011.01386.x","article-title":"Animal models of schizophrenia","volume":"164","author":"Jones","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.neulet.2016.09.020_bib0095","doi-asserted-by":"crossref","first-page":"e0143751","DOI":"10.1371\/journal.pone.0143751","article-title":"Abnormal motor activity and thermoregulation in a schizophrenia rat model for translational science","volume":"10","author":"Horvath","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2016.09.020_bib0100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbr.2016.03.051","article-title":"Electrophysiological alterations in a complex rat model of schizophrenia","volume":"307","author":"Horvath","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2016.09.020_bib0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbr.2015.02.015","article-title":"Sex-specific alterations in behavioral and cognitive functions in a three hit animal model of schizophrenia","volume":"284","author":"Kekesi","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2016.09.020_bib0110","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bbr.2012.11.022","article-title":"Characterization of gene-environment interactions by behavioral profiling of selectively bred rats: the effect of NMDA receptor inhibition and social isolation","volume":"240","author":"Petrovszki","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2016.09.020_bib0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbr.2016.06.021","article-title":"Towards the development of improved tests for negative symptoms of schizophrenia in a validated animal model","volume":"312","author":"Sahin","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2016.09.020_bib0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neubiorev.2016.03.017","article-title":"A review of vulnerability and risks for schizophrenia: beyond the two hit hypothesis","volume":"65","author":"Davis","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neulet.2016.09.020_bib0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neulet.2016.02.060","article-title":"Mu-Opioid (MOP) receptor mediated G-protein signaling is impaired in specific brain regions in a rat model of schizophrenia","volume":"619","author":"Sz\u00fccs","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2016.09.020_bib0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1097-4547(19970501)48:3<249::AID-JNR7>3.0.CO;2-F","article-title":"Met5-enkephalin-Arg6-Phe7 an endogenous neuropeptide, binds to multiple opioid and nonopioid sites in rat brain","volume":"48","author":"Benyhe","year":"1997","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neulet.2016.09.020_bib0135","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neulet.2016.09.020_bib0140","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0026-895X(25)08634-1","article-title":"Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)-triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells","volume":"47","author":"Traynor","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neulet.2016.09.020_bib0145","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1046\/j.1471-4159.2000.0752478.x","article-title":"Loss of cannabinoid-stimulated guanosine 5\u2019-O-(3-[35S]thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats","volume":"75","author":"Rubino","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2016.09.020_bib0150","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0022-3565(24)37418-X","article-title":"Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5'-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes","volume":"285","author":"Griffin","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2016.09.020_bib0155","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1124\/mol.110.068197","article-title":"Effects of the allosteric antagonist 1-(4-chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 receptor modulation in the cerebellum","volume":"79","author":"Wang","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neulet.2016.09.020_bib0160","article-title":"Role of the endocannabinoid system in the pathophysiology of schizophrenia","author":"Fakhoury","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neulet.2016.09.020_bib0165","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2016.09.020_bib0170","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2174\/156800705774933069","article-title":"Endocannabinoids in the central nervous system: from neuronal networks to behavior","volume":"4","author":"Fride","year":"2005","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.neulet.2016.09.020_bib0175","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","article-title":"Cannabinoid CB2 receptors: immunohistochemical localization in rat brain","volume":"1071","author":"Gong","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2016.09.020_bib0180","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1196\/annals.1432.036","article-title":"Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression","volume":"1139","author":"Onaivi","year":"2008","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.neulet.2016.09.020_bib0185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2826.2008.01671.x","article-title":"Cannabinoid receptors: where they are and what they do","volume":"20","author":"Mackie","year":"2008","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.neulet.2016.09.020_bib0190","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neulet.2016.09.020_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/112_0505","article-title":"Endocannabinoids: synthesis and degradation","volume":"160","author":"Di Marzo","year":"2008","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.neulet.2016.09.020_bib0200","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.biopsych.2015.11.018","article-title":"Therapeutic potential of cannabinoids in psychosis","volume":"79","author":"Leweke","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2016.09.020_bib0205","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/npp.2011.43","article-title":"Paranoid schizophrenia is characterized by increased CB1 receptor binding in the dorsolateral prefrontal cortex","volume":"36","author":"Dalton","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2016.09.020_bib0210","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1586\/ern.11.89","article-title":"Is the highest density of CB1 receptors in paranoid schizophrenia a correlate of endocannabinoid system functioning?","volume":"11","author":"Zuardi","year":"2011","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neulet.2016.09.020_bib0215","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12264-007-0051-9","article-title":"No changes in densities of cannabinoid receptors in the superior temporal gyrus in schizophrenia","volume":"23","author":"Deng","year":"2007","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neulet.2016.09.020_bib0220","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.biopsych.2015.06.015","article-title":"The role of endocannabinoid signaling in cortical inhibitory neuron dysfunction in schizophrenia","volume":"79","author":"Volk","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2016.09.020_bib0225","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.neuropharm.2008.07.026","article-title":"Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in rats","volume":"55","author":"Wiley","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2016.09.020_bib0230","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1037\/a0019295","article-title":"Cognitive function as an emerging treatment target for marijuana addiction","volume":"18","author":"Sofuoglu","year":"2010","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.neulet.2016.09.020_bib0235","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.euroneuro.2014.04.003","article-title":"Repeated but not acute treatment with \u0394\u2079-tetrahydro-cannabinol disrupts prepulse inhibition of the acoustic startle: reversal by the dopamine D\u2082\/\u2083 receptor antagonist haloperidol","volume":"24","author":"Tournier","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2016.09.020_bib0240","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0197-0186(99)00020-0","article-title":"Cannabinoid receptor and WIN-55, 212-2-stimulated [35S]GTP\u03b3S binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide","volume":"34","author":"Romero","year":"1999","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neulet.2016.09.020_bib0245","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.bjp.0704297","article-title":"Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes","volume":"134","author":"Savinainen","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neulet.2016.09.020_bib0250","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1528-1167.2012.03460.x","article-title":"Statistical parametric mapping reveals regional alterations in cannabinoid CB1 receptor distribution and G-protein activation in the 3D reconstructed epileptic rat brain","volume":"53","author":"Sayers","year":"2012","journal-title":"Epilepsia"},{"issue":"Suppl. 1","key":"10.1016\/j.neulet.2016.09.020_bib0255","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1590\/S1807-59322011001300009","article-title":"The role of the cerebellum in schizophrenia: from cognition to molecular pathways","volume":"66","author":"Yeganeh-Doost","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.neulet.2016.09.020_bib0260","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pnpbp.2010.11.002","article-title":"The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects","volume":"35","author":"Hallak","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2016.09.020_bib0265","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.euroneuro.2015.12.009","article-title":"Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia: possible involvement of the endocannabinoid system","volume":"26","author":"Seillier","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2016.09.020_bib0270","doi-asserted-by":"crossref","first-page":"10707","DOI":"10.1523\/JNEUROSCI.3502-04.2004","article-title":"Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons","volume":"24","author":"Melis","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2016.09.020_bib0275","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1017\/S1461145708009371","article-title":"Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia","volume":"12","author":"Vigan\u00f2","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2016.09.020_bib0280","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neuroscience.2007.10.043","article-title":"Effect of social isolation on CB1 and D2 receptor and fatty acid amide hydrolase expression in rats","volume":"152","author":"Malone","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2016.09.020_bib0285","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.brainres.2010.04.031","article-title":"The effect of social isolation on rat brain expression of genes associated with endocannabinoid signalling","volume":"1343","author":"Robinson","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2016.09.020_bib0290","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/j.1476-5381.2012.02095.x","article-title":"Chronic blockade of CB(1) receptors reverses startle gating deficits and associated neurochemical alterations in rats reared in isolation","volume":"167","author":"Zamberletti","year":"2012","journal-title":"Br. J. Pharmacol."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394016306930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394016306930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T15:08:26Z","timestamp":1749568106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394016306930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":58,"alternative-id":["S0304394016306930"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2016.09.020","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2016.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}